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Figure S1. PodA reaction and kinetics. (A) PodA reaction schematic of PYO conversion to 1-
OH-PHZ. PYO, pyocyanin; 1-OH-PHZ, 1-hydroxyphenazine. (B) PodA (3 µM) and PYO 
(concentrations indicated on x-axis) were incubated and monitored at 690 nm. Vmax values were 
plotted against [PYO] and KM was calculated by fitting data to the Michaelis-Menten equation as 
indicated by black line.  Each data point represents the mean of three replicates and error bars 
represent standard deviation. 
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Figure S2. Ca2+ ion binding site of PodA. The loop between residues 56-66 connecting the ends 
of anti-parallel β-strands is stabilized through multiple bonds between a Ca2+ ion and loop 
backbone atoms and sidechains, mainly through Asp56 and Asp66. This Ca2+ ion was present in 
the crystal structure upon which our design calculations were based, likely due to the crystal having 
formed in a buffer that contained calcium (3).
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Figure S3. Gel electrophoresis of PodAWT and protein design variants of PodA 
overexpression cultures. Inclusion bodies from overexpression cultures of designed variants were 
analyzed using BugBuster™.  A representative SDS-PAGE gel is shown for PodA1-PodA3. 






Figure S4. Activity of WT PodA30-162 and PodA10 after boiling. Protein was boiled as described 
in Materials and Methods, followed by an activity assay with PodA (3 µM) and PYO (100 µM) in 
a Spectramax M3 plate reader monitoring PYO absorbance (690 nm) overtime. Specific activity 
(nmol min-1 mg-1) was calculated for each sample. Replicates of PodAWT un-boiled were averaged 
and set to 100% activity (dashed line). All other activities of boiled samples were compared to this 
value and presented as a percentage. Data represent technical triplicates and error bars represent 
standard deviation. A t-test was completed, with * representing a p-value < 0.05 and ns 





Figure S5. Sequence logo of diversified positions. Sequence logo representing residue 
observations in evolutionary analysis, generated with default parameters using 
http://www.cbs.dtu.dk/biotools/Seq2Logo/ (1). Most successful designs did not use the most 
conserved residue in each position. For example, both PodA8 and PodA10 incorporated A53N, 
although Ala, Glu and Thr are evolutionarily more likely for this position. In addition, in position 
129 the only preferable amino acid is Ala, but PodA8 and PodA10 mutated to A129V and A129T, 
respectively.  
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Figure S6. Kinetics of PodA in growth media. Using a continuous spectrophotometric assay as 
described in the Material and Methods, PodA (3 µM) and PYO (concentrations indicated on x-
axis) were incubated and monitored at 690 nm. Vmax values were plotted against [PYO] and an KM 
was calculated by fitting data to the Michaelis-Menten equation as indicated by black line.  Each 




Figure S7. Pseudomonas PodA10 and antibiotic synergy experiments in LB and SCFM. 
Growth curves represent outgrowth of cells that were incubated in LB (A) or SCFM (C) with 
PodA and no tobramycin (top left), or varying amounts of tobramycin (indicated in titles). Buffer 
was added in lieu of protein for 0 µM PodA controls. Growth was monitored at OD500 over time 
using a BioTek Plate Reader. Experiment was repeated in triplicate with a representative graph 
shown. Error bars represent the standard error of the mean of triplicates. B) and D) Lag times of 
cultures were calculated from growth curves in respective panels. Data were fit to the Gompertz 
curve-fitting model using Growth Curve Fitting program in R (https://scott-h-
saunders.shinyapps.io/gompertz_fitting_0v2/). Data represent the mean and standard error of 




Figure S8. Cell viability counts of P. aeruginosa cells that are unable to synthesize PYO. A) 
The P. aeruginosa strain lacking phzM (a gene encoding the enzyme PhzM, a S-
adenosylmethionine-dependent N-methyltransferase, that converts phenzine-1-carboxylic acid to 
the PYO precursor, 1-Me-PCA) was grown to stationary phase and incubated with PodA10 (0 
µM or 5 µM) and tobramycin (concentrations indicated on x-axis) for LB. Data represent the 
mean of biological triplicates with error bars representing the standard error of the mean. B) P. 
aeruginosa cells were inoculated in a 96-well polystyrene plate containing minimal medium with 
arginine (40 mM) and either no PodA, WT PodA30-162, PodA10, or inactive PodA10 (i.e. 
PodA10H121A,E154A,Y156A), followed by incubation at 37 °C. After 24 h of growth, planktonic cells 
were washed away, and attached cells were stained with crystal violet, de-stained, and 





Figure S9. Pseudomonas LB and SCFM ABBA oxygen profiles. Cells were inoculated in LB 
or SCFM ABBAs and grown for the time indicated in graph legends. Oxygen profiles were 
determined using a micrometer oxygen sensor (UniSense). All time points consisted of 
biological triplicates with technical triplicate readings of each ABBA block with error bars 
representing standard deviation. A) Oxygen profile time course of LB ABBA. B) Oxygen profile 




Figure S10. Pseudomonas LB and SCFM ABBA aggregate volume analyses. ABBA data from 
Fig. 4 were analyzed in Imaris to obtain PI mean intensity for LB (A) and SCFM (B), along with 
the volume of each aggregate for LB (C) and SCFM (D). Each point represents a single aggregate. 
Mean aggregate volume was calculated with a bin size of 20 (every 25 µm) and plotted as a solid 
line. Propidium Iodide intensity from Fig. 4 was plotted against each aggregate volume for LB (E) 
and SCFM (F).   
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Figure S11. Differences of PI staining in LB between untreated and PodA treated ABBAs. 
Microscopy data LB ABBAs were analyzed in the XY-plane at 90 µm depth (stack 15/84), with 
brightness contrast normalized to the no treatment control. Example of ring staining pattern 
indicated by zooming in on dashed boxes, with zoomed in images in the upper right corner. Look 




Table S1. Bacterial strains used in this study 
Strain   Relative Genotype Source 
E. coli strains 
E. coli DH5α Φ80dlacZ∆M15 recA1 endA1 gyrA96 thi-1 hsdR17 
(rk-, mk+) supE44 relA1 deoR ∆ (lacZYA-argF) U169 
phoA 
NEB 
E. coli BL21 (λDE3) B F- ompT gal dcm lon hsdS (rBmB) gal (λDE3) NEB 
P. aeruginosa strains 
DKN263 Pseudomonas aeruginosa wildtype UCBPP-14  Lab Collection  




Table S2. Plasmids used in this study 
Plasmid Genotype Source 
pTEV16 lacI+ bla+ (2) 
Overexpression plasmids  
pET20b(+)-podA D68A M. fortuitum PodAD68A in pET20b (+) (3) 
pET20b(+)-podA D72A M. fortuitum PodAD72A in pET20b (+) (3) 
pET20b(+)-podA H121A M. fortuitum PodAH121A in pET20b (+) (3) 
pET20b(+)-podA E154A M. fortuitum PodAE154A in pET20b (+) (3) 
pET20b(+)-podA Y156A M. fortuitum PodAY156A in pET20b (+) (3) 
pPodA1 Mycobacterium fortuitum podA30-162+ cloned into pTEV16 
with a TEV cleavable 6X-His tag 
This study 
pPodA2 Mycobacterium fortuitum podA designed variant cloned into 
pTEV16 with a TEV cleavable 6X-His tag: I73K, A87V, 
T91V, M99T, A128V 
This study 
pPodA3 Mycobacterium fortuitum podA designed variant cloned into 
pTEV16 with a TEV cleavable 6X-His tag: I73T, A87V, 
T91V, M99V, A128V 
This study 
pPodA4 Mycobacterium fortuitum podA designed variant cloned into 
pTEV16 with a TEV cleavable 6X-His tag: I73K, A87V, 
M99T, A129V, K141T 
This study 
pPodA5 Mycobacterium fortuitum podA designed variant cloned into 
pTEV16 with a TEV cleavable 6X-His tag: I73E, A87V, 
M99I, A129V, K141T 
This study 
pPodA6 Mycobacterium fortuitum podA designed variant cloned into 
pTEV16 with a TEV cleavable 6X-His tag: I73L, A87I, 
M99V, A129V, K141T 
This study 
pPodA7 Mycobacterium fortuitum podA designed variant cloned into 
pTEV16 with a TEV cleavable 6X-His tag: I73R, A87V, 
T91V, M99V, A129T 
This study 
pPodA8 Mycobacterium fortuitum podA Sarel designed variant cloned 
into pTEV16 with a TEV cleavable 6X-His tag: I73L, A87I, 
T91V, M99T, A129V 
This study 
pPodA9 Mycobacterium fortuitum podA designed variant cloned into 
pTEV16 with a TEV cleavable 6X-His tag: A53N, I73R, 
A87V, T91V, A129V 
This study 
pPodA10 Mycobacterium fortuitum podA designed variant cloned into 
pTEV16 with a TEV cleavable 6X-His tag: I73K, A87V, 
T91V, A129V, K141T 
This study 
pPodA11 Mycobacterium fortuitum podA designed variant cloned into 
pTEV16 with a TEV cleavable 6X-His tag: A53N, I73T, 
A87V, M99V, A129T 
This study 
pPodA12 Mycobacterium fortuitum inactive PodA10 cloned into 
pTEV16 with a TEV cleavable 6X-His tag: A53N, I73T, 






Table S3. Primers used in this study 
Primer Name Primer Sequence 5’ --> 3’ 
Overexpression primers 
5’ podA pTEV16  NNGCTCTTCNTTCATGGACGGTCGCGGCGGCCGGAGTACAA 
3’ podA pTEV16 NNGCTCTTCNTAATCATTTCGTCAGTTTCAATTCGTACTTCTC 
5’ pTEV16 gibson GCCCTGAAAATACAGGTTTTCACTAGTTG  
3’ pTEV16 gibson TAAGAATTCTCGAGCTCCCGGGATC 
5’ podA gBlock gibson ATTACGATATCCCAACTAGTGAAAACCTGTATTTTCAGGGC 
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